Susquehanna Fundamental Investments, LLC Assertio Holdings, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.52 - $5.69 $131,574 - $297,086	-52,212 Reduced 69.13%	23,317 $59,000
Q2 2023 Aug 11, 2023	SELL	$5.0 - $7.66 $771,425 - $1.18 Million	-154,285 Reduced 67.13%	75,529 $409,000
Q1 2023 May 16, 2023	SELL	$3.54 - $6.66 $28,925 - $54,418	-8,171 Reduced 3.43%	229,814 $1.46 Million
Q4 2022 Feb 14, 2023	SELL	$2.11 - $4.3 $26,782 - $54,579	-12,693 Reduced 5.06%	237,985 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $533,944 - $1 Million	250,678 New	250,678 $569,000

114

37.2M

755K

39.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $58.8M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.